The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...

Up to 8 in 10 Americans carry a common viral infection that may raise the risk of developing Alzheimer’s disease, new research suggests.

This new AI Alzheimer’s detection model was trained on the transcribed speech of 166 older adults diagnosed with mild cognitive impairment (MCI), a condition that often precedes Alzheimer’s.

The FDA's sign-off on marketing for Fujirebio's test comes years after other blood tests for Alzheimer's have already begun sales, without this kind of approval from the agency.

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, according to a new study.

The first Alzheimer's blood test from Fujirebio Diagnostics, now approved by FDA, could help patients with the disease get treatment faster. Skip to Main Content Manage alerts for this article ...

About 7 million U.S. residents aged 65 and older have Alzheimer’s, the nation’s seventh-leading cause of death. Given the cresting age wave, the number is expected to roughly double in the ...

Topline. The first blood test used to diagnose Alzheimer’s disease was cleared by the Food and Drug Administration for marketing Friday, meaning the laboratory test can be marketed and sold in ...

Alzheimer's Association says the nation needs to take charge of their brain health, nothing as many as 45% of dementia cases may be avoided through healthy changes. Skip Navigation.

A survey of 1,700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's disease. Accessibility links. Skip to main content; ...

The F.D.A., and Alzheimer’s experts, emphasized that the blood test should be given only to people who are already experiencing cognitive decline and are ages 55 and older.

People who follow a MIND diet, even if started later in life, were significantly less likely to develop Alzheimer's disease or related forms of dementia, according to new research.